MAYINGLONG HEMORRHOIDS- zinc oxide, petrolatum, lanolin ointment

MAYINGLONG HEMORRHOIDS by

Drug Labeling and Warnings

MAYINGLONG HEMORRHOIDS by is a Otc medication manufactured, distributed, or labeled by Mayinglong Pharmaceutical Group Co Ltd. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

Active Ingredients

Zinc Oxide 0.8g Astrigent

Petrolatum 7.85g Protectant

Purpose

Astrigent

Protectant

Protectant

Uses

helps relieve the local itching and discomfort associated with hemorrhoids

temporarily shrinks hemorrhoidal tissue and relieves burning

temporarily provides a coating for relief of anorectal discomforts

temporarily protects the inflamed, irritated anorectal surface to help make bowel movements less painful

Warning

For external and /or intrarectal use only. Not for oral use.

Stop use

bleeding occurs

condition worses or does not improve within 7 days

introduction of applicator into the rectum causes additional pain

Warning

Apply it carfully during pregnancy.

Warning

Keep this and all drugs out of reach of children.

Direction

Apply properly onto anus or apply on affected areas twice a day.

Other information

Store at 20-25 degree Centigrade (68-77 degree Fahrenheit)

Inactive ingredients

Musk Ketone

Pearl (Hyriopsis Cumming II)

Borneol

Sodium Borate

Drug Facts

INGREDIENTS AND APPEARANCE

MAYINGLONG HEMORRHOIDS 
zinc oxide, petrolatum, lanolin ointment

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 68511-993
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
ZINC OXIDE (UNII: SOI2LOH54Z) (ZINC OXIDE - UNII:SOI2LOH54Z)	ZINC OXIDE	800 mg  in 10000 mg
PETROLATUM (UNII: 4T6H12BN9U) (PETROLATUM - UNII:4T6H12BN9U)	PETROLATUM	7850 mg  in 10000 mg

Inactive Ingredients
Ingredient Name	Strength
MUSK KETONE (UNII: 483V3E1L6J)
PEARL (HYRIOPSIS CUMINGII) (UNII: A75L5FZ40U)
BORNEOL (UNII: M89NIB437X)
SODIUM BORATE (UNII: 91MBZ8H3QO)
LANOLIN (UNII: 7EV65EAW6H)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 68511-993-01	10000 mg in 1 CARTON; Type 0: Not a Combination Product	10/25/2017

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC monograph final	part346	12/15/2003

Labeler - Mayinglong Pharmaceutical Group Co Ltd (526823828)

Registrant - Mayinglong Pharmaceutical Group Co Ltd (526823828)

Establishment
Name	Address	ID/FEI	Business Operations
Mayinglong Pharmaceutical Group Co Ltd		526823828	manufacture(68511-993)